NAS:CRSP () Also Trade In: Germany UK

CRISPR Therapeutics AG $ 94.51 -0.06 (-0.06%)

Volume:
967,165
Avg Vol (1m):
1,139,165
Market Cap $:
6.63 Bil
Enterprise Value $:
5.74 Bil
P/E (TTM):
205.46
P/B:
6.37
Warning! GuruFocus has detected 1 Severe warning sign with CRSP. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

CRSP Stock Institutional Ownership and Insider Ownership - CRISPR Therapeutics AG

70.17
(Mil)
Shares Outstanding
46.38%
25.35 (Mil)
Institutional Ownership
2.14%
1.50 (Mil)
Insider Ownership
87.92%
61.6901 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of CRISPR Therapeutics AG. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED

Insider ownership (%)

This is the historical insider ownership of CRISPR Therapeutics AG. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders